Skip to main content
PMC home page
The BMJ logoLink to The BMJ
. 1994 Apr 2;308(6933):891–894. doi: 10.1136/bmj.308.6933.891

Deep venous thrombosis and occult malignancy: an epidemiological study.

M Nordström 1, B Lindblad 1, H Anderson 1, D Bergqvist 1, T Kjellström 1
PMCID: PMC2539869  PMID: 8173368

Abstract

OBJECTIVE--To determine the risk of subsequent cancer in patients with deep venous thrombosis confirmed by venography. DESIGN--Follow up of all patients who had venography for suspected deep venous thrombosis during 1984-88. Patients were traced through a cancer registry up to 1 January 1991. SUBJECTS--4399 patients who had phlebography in one hospital. SETTING--General hospital in Malmö, Sweden, serving a population of 230,000. MAIN OUTCOME MEASURE--Number of cancers recorded. RESULTS--4399 patients had venography for suspected deep venous thrombosis; 604 were known to have a malignancy at the time of venography and were excluded from further analysis. 1383 had deep venous thrombosis, 150 of whom subsequently developed cancer. 182 of the 2412 patients without thrombosis developed cancer. During the first six months after venography 66 patients with thrombosis developed malignancy compared with 37 patients without thrombosis (P < 0.0001). 38 of the cancers in the deep venous thrombosis group were detected by history, physical examination, and laboratory tests. Three patients had postoperative or post-traumatic deep venous thromboses. Only two of the remaining patients would have benefited from early detection by extensive screening. After six months the incidence of cancer was identical in patients with and without thrombosis. CONCLUSION--Deep venous thrombosis is associated with a significantly higher frequency of malignancy during the first six months after diagnosis. Malignancies can be found with simple clinical and diagnostic methods and extensive screening is not required.

Full text

PDF
891

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Carlsson U., Ekelund G., Lindström C., Möller T. Kolorektal cancer vanligare i Malmö än i övriga landet? En validitetsstudie av cancerregistret. Lakartidningen. 1986 Feb 19;83(8):598–603. [PubMed] [Google Scholar]
  2. Goldberg R. J., Seneff M., Gore J. M., Anderson F. A., Jr, Greene H. L., Wheeler H. B., Dalen J. E. Occult malignant neoplasm in patients with deep venous thrombosis. Arch Intern Med. 1987 Feb;147(2):251–253. [PubMed] [Google Scholar]
  3. Greenland S., Robins J. M. Estimation of a common effect parameter from sparse follow-up data. Biometrics. 1985 Mar;41(1):55–68. [PubMed] [Google Scholar]
  4. Griffin M. R., Stanson A. W., Brown M. L., Hauser M. F., O'Fallon W. M., Anderson H. M., Kazmier F. J., Melton L. J., 3rd Deep venous thrombosis and pulmonary embolism. Risk of subsequent malignant neoplasms. Arch Intern Med. 1987 Nov;147(11):1907–1911. [PubMed] [Google Scholar]
  5. Levine M. N., Drummond M. F., Labelle R. J. Cost-effectiveness in the diagnosis and treatment of carcinoma of unknown primary origin. CMAJ. 1985 Nov 15;133(10):977–987. [PMC free article] [PubMed] [Google Scholar]
  6. Levine M., Hirsh J. The diagnosis and treatment of thrombosis in the cancer patient. Semin Oncol. 1990 Apr;17(2):160–171. [PubMed] [Google Scholar]
  7. Mattsson B., Wallgren A. Completeness of the Swedish Cancer Register. Non-notified cancer cases recorded on death certificates in 1978. Acta Radiol Oncol. 1984;23(5):305–313. doi: 10.3109/02841868409136026. [DOI] [PubMed] [Google Scholar]
  8. Monreal M., Lafoz E., Casals A., Inaraja L., Montserrat E., Callejas J. M., Martorell A. Occult cancer in patients with deep venous thrombosis. A systematic approach. Cancer. 1991 Jan 15;67(2):541–545. doi: 10.1002/1097-0142(19910115)67:2<541::aid-cncr2820670237>3.0.co;2-j. [DOI] [PubMed] [Google Scholar]
  9. Myrup B. Dyb tromboflebit og lungeembolus som tegn på malign sygdom. Ugeskr Laeger. 1991 Oct 21;153(43):2996–2998. [PubMed] [Google Scholar]
  10. Naschitz J. E., Yeshurun D., Abrahamson J. Incidence and diagnostic significance of paraneoplastic thromboembolism disorders. A survey from a community hospital. Int Angiol. 1989 Jan-Mar;8(1):28–31. [PubMed] [Google Scholar]
  11. Nordström M., Lindblad B., Bergqvist D., Kjellström T. A prospective study of the incidence of deep-vein thrombosis within a defined urban population. J Intern Med. 1992 Aug;232(2):155–160. doi: 10.1111/j.1365-2796.1992.tb00565.x. [DOI] [PubMed] [Google Scholar]
  12. Prandoni P., Lensing A. W., Büller H. R., Cogo A., Prins M. H., Cattelan A. M., Cuppini S., Noventa F., ten Cate J. W. Deep-vein thrombosis and the incidence of subsequent symptomatic cancer. N Engl J Med. 1992 Oct 15;327(16):1128–1133. doi: 10.1056/NEJM199210153271604. [DOI] [PubMed] [Google Scholar]
  13. Ranft J., Heidrich H. Frequency of malignant diseases in deep venous thrombosis of the lower extremities. Int Angiol. 1991 Apr-Jun;10(2):66–68. [PubMed] [Google Scholar]
  14. WRIGHT I. S. The pathogenesis and treatment of thrombosis. Circulation. 1952 Feb;5(2):161–188. doi: 10.1161/01.cir.5.2.161. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES